![Clarence Machado](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clarence Machado
Président chez
ADVERUM BIOTECHNOLOGIES, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Clarence Patrick Machado is the founder of Medivation, Inc. and Medivation LLC (California), both founded in 1995.
Titles held at these companies include Director from 2014 to 2016.
Current jobs include Chairman at Adverum Biotechnologies, Inc. since 2019, Chairman at Prota Therapeutics Pty Ltd., Independent Director at Xenon Pharmaceuticals, Inc. since 2020, Independent Director at Arcus Biosciences, Inc. since 2019, Director at Auransa, Inc., Independent Director at Alumis, Inc. since 2024, and Director at Avenzo Therapeutics, Inc. Former jobs include Chairman at Armaron Bio Ltd., Independent Director at Inotek Pharmaceuticals Corp.
from 2016 to 2018, Independent Director at ACELYRIN, Inc. from 2021 to 2025, Director at Principia Biopharma, Inc. from 2019 to 2020, Independent Director at Turning Point Therapeutics, Inc. from 2019 to 2022, Independent Director at Roivant Sciences Ltd. from 2016 to 2022, Independent Director at Endocyte, Inc. in 2018, Chief Financial Officer, Director & Senior VP at Medivation Neurology LLC from 2003 to 2004, Director at Roivant Sciences, Inc., Director at Sio Gene Therapies, Inc. from 2017 to 2018, Director at Axovant Sciences, Inc. from 2017 to 2018, Independent Director at Montes Archimedes Acquisition Corp., Independent Director at Turnstone Biologics Corp.
from 2018 to 2024, Director at Therachon AG in 2019, Independent Director at Chimerix, Inc. from 2014 to 2024, Independent Director at SCYNEXIS, Inc. from 2015 to 2019, Chief Legal Counsel at Chiron Corp., Chief Financial Officer at Orion Acquisition Corp.
II, Consultant at Cytyc Corp.
in 2002, Principal at Morrison & Foerster LLP, Chief Financial Officer & Senior Vice President at Pro-Duct Health, Inc. from 2000 to 2001, and Member-Supervisory Board at Therachon Holding GmbH.
Education includes an undergraduate degree from Santa Clara University conferred in 1986 and a graduate degree from Harvard Law School conferred in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 44 300 ( 0,04% ) | 1 M $ | 31/05/2026 | |
ALUMIS INC. 0,01% | 05/05/2026 | 7 064 ( 0,01% ) | 152 582 $ | 31/05/2026 |
| 03/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Clarence Machado
| Sociétés | Poste | Début |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Président | 01/05/2019 |
| ARCUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 10/12/2019 |
| XENON PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 05/11/2020 |
| ALUMIS INC. | Directeur/Membre du Conseil | 01/06/2024 |
ProTA Therapeutics Pty Ltd.
 ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Président | - |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Directeur/Membre du Conseil | - |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Clarence Machado
| Sociétés | Poste | Fin |
|---|---|---|
| ACELYRIN, INC. | Directeur/Membre du Conseil | 21/05/2025 |
| CHIMERIX, INC. | Directeur/Membre du Conseil | 20/06/2024 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Clarence Machado
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
33
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 33 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Orion Acquisition Corp. II
 Orion Acquisition Corp. II Financial ConglomeratesFinance Development stage company | Finance |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Develops medical products for the evaluation of breast cancer | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Medivation, Inc. /Old/
 Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Develops and produces biopharmaceutical products | Health Technology |
Armaron Bio Ltd.
 Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops cardioprotection and neuroprotection small molecules to reduce tissue damage for heart attacks | Electronic Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Health Technology |
ProTA Therapeutics Pty Ltd.
ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Therachon AG | |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
